1. Home
  2. NGVT vs PGEN Comparison

NGVT vs PGEN Comparison

Compare NGVT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingevity Corporation

NGVT

Ingevity Corporation

N/A

Current Price

$59.90

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.42

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGVT
PGEN
Founded
1964
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
NGVT
PGEN
Price
$59.90
$4.42
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
★ $89.00
$13.65
AVG Volume (30 Days)
293.3K
★ 5.6M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.10
N/A
EPS
★ 4.08
0.12
Revenue
★ $1,167,600,000.00
$230,981,000.00
Revenue This Year
N/A
$2,335.22
Revenue Next Year
$1.74
$85.34
P/E Ratio
★ $18.07
$42.13
Revenue Growth
N/A
★ N/A
52 Week Low
$46.38
$3.04
52 Week High
$79.29
$8.98

Technical Indicators

Market Signals
Indicator
NGVT
PGEN
Relative Strength Index (RSI) 25.62 29.53
Support Level N/A $3.50
Resistance Level $77.21 $4.56
Average True Range (ATR) 2.66 0.45
MACD -0.98 -0.23
Stochastic Oscillator 2.65 13.20

Price Performance

Historical Comparison
NGVT
PGEN

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: